J Korean Med Sci.  2014 Feb;29(2):164-171. 10.3346/jkms.2014.29.2.164.

Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines

• Bang SM
• Jang MJ
• Kim KH
• Yhim HY
• Kim YK
• Nam SH
• Hwang HG
• Bae SH
• Kim SH
• Mun YC
• Kim YK
• Kim I
• Choi WI
• Jung CW
• Park NH
• Choi NK
• Park BJ
• Oh D

• KMID: 1789970
• DOI: http://doi.org/10.3346/jkms.2014.29.2.164

Abstract

In 2010, we proposed the first Korean Guidelines for the Prevention of Venous Thromboembolism (VTE). It was applicable to Korean patients, by modifying the contents of the second edition of the Japanese guidelines for the prevention of VTE and the 8th edition of the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. From 2007 to 2011, we conducted a nationwide study regarding the incidence of VTE after major surgery using the Health Insurance Review and Assessment Service (HIRA) database. In addition, we have considered the 9th edition of the ACCP Evidenced-Based Clinical Practice Guidelines, published in 2012. It emphasized the importance of clinically relevant events as opposed to asymptomatic outcomes with preferences for both thrombotic and bleeding outcomes. Thus, in the development of the new Korean guidelines, three major points were addressed: 1) the new guidelines stratify patients into 4 risk groups (very low, low, moderate, and high) according to the actual incidence of symptomatic VTE from the HIRA databases; 2) the recommended optimal VTE prophylaxis for each group was modified according to condition-specific thrombotic and bleeding risks; 3) guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and/or physician advice.

Keyword

Guideline; Prevention; Venous Thromboembolism; Bleeding

MeSH Terms

Age Factors
Anticoagulants/adverse effects/*therapeutic use
Asian Continental Ancestry Group
Evidence-Based Medicine
Heparin, Low-Molecular-Weight/therapeutic use
Humans
*Mechanical Thrombolysis
Neoplasms/complications/surgery
Republic of Korea
Risk Assessment
Surgical Procedures, Operative/adverse effects
Venous Thromboembolism/etiology/prevention & control/*therapy
Anticoagulants
Heparin, Low-Molecular-Weight

Reference

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991; 151:933–938.

2. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010; 38:S495–S501.

3. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR Surveill Summ. 2003; 52:1–8.

4. Ruppert A, Steinle T, Lees M. Economic burden of venous thromboembolism: a systematic review. J Med Econ. 2011; 14:65–74.

5. Cardiovascular Disease Educational and Research Trust. Cyprus Cardiovascular Disease Educational and Research Trust. European Venous Forum. International Surgical Thrombosis Forum. International Union of Angiology. Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism: International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006; 25:101–161.

6. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:7S–47S.

7. Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, et al. Asian venous thromboembolism guidelines: prevention of venous thromboembolism. Int Angiol. 2012; 31:501–516.

8. Wickham N, Gallus AS, Walters BN, Wilson A. NHMRC VTE Prevention Guideline Adaptation Committee. Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. Intern Med J. 2012; 42:698–708.

9. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost. 2011; 9:85–91.

10. Bang SM, Jang MJ, Oh DY, Kim YK, Kim IH, Yoon SS, Yoon HJ, Kim CS, Park SY. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci. 2010; 25:1553–1559.

11. Bang SM, Jang MJ, Kim KH, Yhim HY, Kim YK, Bae SH, Kim SH, Mun YC, Kim IH, Jung CW. Incidence of venous thromboembolism (VTE) after major surgeries and proposal of evidence-based Korean guidelines for the prevention of VTE. In : Reitsma P, Rosendaal F, Levi M, editors. XXIV Congress of the International Society on Thrombosis and Haemostasis and 59th annual SSC meeting. Amsterdam: Wiley-Blackwell;2013. accessed on 6 January 2013. 339. Available at http://www.eventure-online.com/eventure/publicAbstractView.do?id=215660&congressId=6839.

12. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992; 152:1660–1664.

13. Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M, Vandvik PO, Eikelboom JW, McDonagh MS, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:53S–70S.

14. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:e278S–e325S.

15. Leizorovicz A, Turpie AG, Cohen AT, Wong L, Yoo MC, Dans A. SMART Study Group. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis: the SMART Study. J Thromb Haemost. 2005; 3:28–34.

16. Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998; 339:80–85.

17. Black PM, Baker MF, Snook CP. Experience with external pneumatic calf compression in neurology and neurosurgery. Neurosurgery. 1986; 18:440–444.

18. Jang MJ, Bang SM, Oh D. Incidence of pregnancy-associated venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost. 2011; 9:2519–2521.

19. Ageno W, Crotti S, Turpie AG. The safety of antithrombotic therapy during pregnancy. Expert Opin Drug Saf. 2004; 3:113–118.

20. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006; 21:271–276.

21. Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Clinically significant venous thromboembolism after gynecologic surgery. J Reprod Med. 1999; 44:669–673.

22. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994; 331:1601–1606.

23. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004; 240:490–496.

24. Shackford SR, Davis JW, Hollingsworth-Fridlund P, Brewer NS, Hoyt DB, Mackersie RC. Venous thromboembolism in patients with major trauma. Am J Surg. 1990; 159:365–369.

25. Merli GJ, Crabbe S, Paluzzi RG, Fritz D. Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury. Arch Phys Med Rehabil. 1993; 74:1199–1205.

26. DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999; 80:1411–1419.

27. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003; 28:172–197.

28. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004; 101:950–959.

29. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994; 79:1165–1177.

30. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126:338S–400S.

31. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001; 38:12–19.

32. Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A. Prevention of venous thromboembolism: International Consensus Statement: guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001; 20:1–37.

33. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999; 341:793–800.

34. Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991; 17:313–318.

35. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010; 8:2450–2457.

36. Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011; 140:706–714.